Overall rank by patents
#4,436
Across all tracked assignees
USPTO PatentsView assignee record - 80 granted patents across 5 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR).
The verdict
Silk holds 80 US patents across 5 technology areas, rank #4,436 of 50,000 tracked assignees.
Silk Road Medical, Inc. has been granted 80 US utility patents between 2015 and 2025, placing Silk Road Medical, Inc. at rank #4,436 across all assignees tracked by PlainPatent. This portfolio spans 5 distinct Cooperative Patent Classification (CPC) subclasses, averaging 14.3 claims per patent with primary concentration in A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR). As a US Corporation, Silk Road Medical, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Silk sits between SK Biopharmaceuticals Co., Ltd. (80 patents, rank #4,432) and Tenacious Holdings, Inc. (80 patents, rank #4,440) - the closest US assignees by grant volume. The composite Innovation Score of 36.1/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 41 grants, compared with 39 in the 2015–2019 window, a +5% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Silk Road Medical, Inc.'s 14.3 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 5 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Silk Road Medical, Inc. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
SK BIOPHARMACEUTICALS CO., LTD.
80 patents
SOKEN, INC.
80 patents
SPM Oil & Gas Inc.
80 patents
SUMITOMO HEAVY INDUSTRIES ION TECHNOLOGY CO., LTD.
80 patents
Southern Research Institute
80 patents
Syniverse Technologies, LLC
80 patents
TOYO INK SC HOLDINGS CO., LTD.
80 patents
Tenacious Holdings, Inc.
80 patents
Silk Road Medical, Inc.
80 patents
What this shows Silk holds 80 patents at rank #4,436, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #4,436 in granted patent volume.
Other assignees with the most granted patents in Silk's primary technology class.
Silk's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
36 Top 47% higher than 53% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 5 | 6.3% |
| 2016 | 7 | 8.8% |
| 2017 | 9 | 11.3% |
| 2018 | 4 | 5.0% |
| 2019 | 14 | 17.5% |
| 2020 | 6 | 7.5% |
| 2021 | 10 | 12.5% |
| 2022 | 5 | 6.3% |
| 2023 | 4 | 5.0% |
| 2024 | 11 | 13.8% |
| 2025 | 5 | 6.3% |
Top 5 of 5 technology areas
Overall rank by patents
#4,436
Across all tracked assignees
36.1 out of 100
How to use this portfolio
Silk's 80 grants land it in the top 47% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.